Global Retirement Partners
SAGE icon

Global Retirement Partners’s Sage Therapeutics SAGE Stock Holding History

Global Retirement Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19
Closed -$356 – 3628
2024
Q1 		$356 Hold
19
– – ﹤0.01% 3192
2023
Q4 		$502 Sell
19
-4
-17% -$79 ﹤0.01% 3083
2023
Q3 		$452 Buy
23
+5
+28% +$144 ﹤0.01% 2981
2023
Q2 		$846 Sell
18
-1
-5% -$50 ﹤0.01% 2826
2023
Q1 		$902 Buy
+19
New +$817 ﹤0.01% 2765
2019
Q4 		– Sell
-4
Closed -$1K – 1688
2019
Q3 		$1K Hold
4
– – ﹤0.01% 1544
2019
Q2 		$1K Buy
+4
New +$683 ﹤0.01% 1538

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Global Retirement Partners's SAGE Position: Q2 2024 in Review

Global Retirement Partners sold out of Sage Therapeutics (SAGE) in Q2 2024, closing a stake of 19 shares — an estimated $356 sold.

Global Retirement Partners first reported a position in SAGE in Q2 2019 and held it in 7 quarters. The position peaked at $1K in Q3 2019. 195 funds tracked by Wall St. Rank hold SAGE as of Q2 2024.

  • Global Retirement Partners reported no remaining Sage Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Global Retirement Partners sold 19 Sage Therapeutics shares in Q2 2024, an estimated $356.
  • Global Retirement Partners first reported a position in Sage Therapeutics in Q2 2019 and held it in 7 quarters.
  • Global Retirement Partners's Sage Therapeutics position peaked at $1K in Q3 2019.
  • 195 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2024.

Based on Global Retirement Partners's 13F filing for Q2 2024, filed 23 Jul 2024.